Results 171 to 180 of about 41,795 (272)

Critical care of the liver transplant patient [PDF]

, 1988
Esquivel, CO, Gordon, RD, Marsh, JW, Starzl, TE, Stieber, A   +4 more
core  

Thrombocytopenia and Leucopenia Following Carbutamide [PDF]

BMJ, 1957
openaire   +2 more sources

Triple HER2 Blockade With Trastuzumab, Pertuzumab, and Pyrotinib Versus Dual HER2 Blockade in the Neoadjuvant Treatment of HER2‐Positive Breast Cancer: A Randomized, Phase II Study

MedComm, Volume 7, Issue 2, February 2026.
Triple HER2 blockade with trastuzumab, pertuzumab, and pyrotinib (TPPy) did not improve total pathological complete response (tpCR) rates or breast pathological complete response (bpCR) rates compared with dual blockade with trastuzumab and pertuzumab (TP), but was associated with greater grade ≥ 3 toxicity, particularly diarrhea.
Jiahui Huang, Haoyu Wang, Yiwei Tong, Jin Hong, Yifei Zhu, Weili Ren, Jing Yu, Haoting Shi, Weiqi Gao, Siji Zhu, Jiayi Wu, Ou Huang, Jing Li, Jianrong He, Weiguo Chen, Yafen Li, Kunwei Shen, Xiaosong Chen   +17 more
wiley   +1 more source

Stem Cell Therapy for Inflammatory Diseases: Progress, Challenges, and Future Directions

MedComm, Volume 7, Issue 2, February 2026.
Stem cells offer multifaceted therapeutic approaches for inflammatory diseases, each exhibiting distinct therapeutic properties. Hematopoietic stem cells, primarily through hematopoietic stem cell transplantation (HSCT), can effectively remodel the immune environment, showing particular promise in treating genetically linked cases.
Chen Wu, Zhi‐Ping Jin, Shu‐Qiang Weng, Ji‐Min Zhu, Ling Dong   +4 more
wiley   +1 more source

Reporting Matters: Severe Adverse Events in Soft Tissue Sarcoma Therapy-A 30-Year Systematic Review of Placebo- and Non-Systemic-Controlled Randomized Trials. [PDF]

Cancers (Basel)
Aeschbacher R, Fuchs B, Studer G, Heesen P.   +3 more
europepmc   +1 more source

Efficacy of Early Switching From Docetaxel to Cabazitaxel in Castration‐Resistant Prostate Cancer

The Prostate, Volume 86, Issue 3, Page 297-306, February 15, 2026.
ABSTRACT Background Cabazitaxel is a taxane agent associated with fewer symptomatic adverse events than docetaxel in treating castration‐resistant prostate cancer (CRPC), yet it is typically reserved for post‐docetaxel failure. This study assessed whether early switching from docetaxel to cabazitaxel could improve clinical outcomes.
Taketo Kawai, Kazuki Maki, Satoru Taguchi, Yoichi Fujii, Takehiro Tanaka, Jimpei Miyakawa, Jun Kamei, Shigenori Kakutani, Aya Niimi, Daisuke Yamada, Yuta Yamada, Tappei Takada, Tohru Nakagawa, Haruki Kume   +13 more
wiley   +1 more source

COVID-19-Related Hematological Abnormalities Among Adults; A Cross-Sectional Study in a Resource-Limited Setting. [PDF]

Immun Inflamm Dis
Nkansah C, Osei-Boakye F, Appiah SK.
europepmc   +1 more source

Filgotinib Is an Effective and Safe Treatment Option for Difficult‐To‐Treat Ulcerative Colitis: Real‐World Evidence of the Dutch Initiative on Crohn and Colitis (ICC) Registry

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Filgotinib is a preferential Janus kinase 1 (JAK‐1) inhibitor registered for the treatment of ulcerative colitis (UC). Real‐world effectiveness of filgotinib, especially for difficult‐to‐treat (DTT, failure of ≥ 2 prior advanced therapies) patients, has been scarcely reported.
M. R. Naber, A.E van der Meulen, P. W. Voorneveld, S. H. C. Veltkamp, A.A. van Bodegraven, A. Bodelier, Z. Mujagic, M. Pierik, L. M. M. Verleye, M. Duijvestein, D. G. Bouwknegt, M. C. Visschedijk, N. Srivastava, R. L. West, B. Oldenburg, M. Löwenberg, F.D.M. van Schaik, On behalf of the Dutch ICC Registry   +17 more
wiley   +1 more source

The Association of Insomnia with Febrile Neutropenia, Leucopenia, and Infection in Women Receiving Adjuvant Chemotherapy for Breast Cancer. [PDF]

Cancers (Basel)
Lemelin A, Savard J, Chen M, Shepherd LE, Burnell M, Levine MN, Chen BE, Lemieux J.   +7 more
europepmc   +1 more source

Abstracts Vol. 1, No . 3 - V o l. 1, No. 4 [PDF]

, 1956

core